Is Hospira owned by Pfizer?
Pfizer acquired Hospira in September 2015 in a deal worth about $17 billion. Hospira, headquartered in Lake Forest, Illinois, develops and markets injectable drugs and infusion technologies.
Is Hospira part of ICU Medical?
The addition of Hospira’s I.V. pumps, solutions, and devices business to ICU Medical’s existing portfolio creates a leading pure-play infusion therapy company with focus and global scale. “We are pleased that Hospira Infusion Systems is now part of ICU Medical and welcome our new Hospira colleagues to the ICU team.
Is ICU Medical owned by Pfizer?
Upon completion of the transaction, which the companies expect to occur in the first quarter of 2017 subject to customary closing conditions including required regulatory approvals, Pfizer will own approximately 16.6 percent of ICU Medical.
Is Viatris a Pfizer company?
A: Viatris is a new company that is the combination of Mylan and Upjohn, a legacy division of Pfizer.
Who is ICU Medical owned by?
Why Hospira Healthcare India?
Established in 2009 , Hospira Healthcare India Pvt. Ltd. has made a name for itself in the list of top suppliers of Medical Equipment ,IV & Infusion Set in India. The supplier company is located in Chennai, Tamil Nadu and is one of the leading sellers of listed products.
Who are Hospira’s competitors in injectable drugs?
Hospira’s competitors in specialty injectable pharmaceuticals include Fresenius AG, Baxter International Inc ., Bedford Laboratories, Mylan, Sandoz, Teva Pharmaceuticals as well as divisions of several multinational pharmaceutical companies.
Who is the new chairman of Hospira?
Hospira named John Staley its non-executive chairman with the retirement of former executive chairman Christopher Begley in January 2012. Begley had announced his retirement as Hospira’s chief executive in August 2010, but had remained as executive chairman.
What did Hospira do before Pfizer?
Before its acquisition by Pfizer, Hospira was the world’s largest producer of generic injectable pharmaceuticals, manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems.